Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases

REFERENCES

• Caramori G, Ito K, Adcock I M. Transcription factors in asthma and COPD. IDrugs 2004; 7(8)764–770
   PubMed Web of Science ®Google Scholar
• Allfrey V G, Faulkner R, Mirsky A E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964; 51: 786–794, may[CSA]
   PubMed Web of Science ®Google Scholar
• Littau V C, Burdick C J, Allfrey V G, Mirsky S A. The role of histones in the maintenance of chromatin structure. Proc Natl Acad Sci USA 1965; 54(4)1204–1212, [CSA]
   PubMed Web of Science ®Google Scholar
• Bannister A J, Kouzarides T. The C BP co-activator is a histone acetyltransferase. Nature 1996; 384(6610)641–643, [CSA]
   PubMed Web of Science ®Google Scholar
• Barnes P J, Pedersen S, Busse W W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157(3 Pt 2)S1–53, [CSA]
   PubMed Web of Science ®Google Scholar
• Barnes P J, Adcock I M. How do corticosteroids work in asthma?. Ann Intern Med 2003; 139(5 Pt 1)359–370, [CSA]
   PubMed Web of Science ®Google Scholar
• Leung D Y, Bloom J W. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003; 111(1)3–22, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes P J, Adcock I M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000; 20(18)6891–6903, [CSA]
   PubMed Web of Science ®Google Scholar
• Yao T P, Ku G, Zhou N, Scully R, Livingston D M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 1996; 93(20)10626–10631, [CSA]
   PubMed Web of Science ®Google Scholar
• Kurihara I, Shibata H, Suzuki T, Ando T, Kobayashi S, Hayashi M, Saito I, Surata T. Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol Cell Endocrinol 2002; 189(1–2)181–189, [CSA]
   PubMed Web of Science ®Google Scholar
• Mittelstadt P R, Ashwell J D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 2001; 276(31)29603–29610, [CSA]
   PubMed Web of Science ®Google Scholar
• Lasa M, Abraham S M, Boucheron C, Saklatvala J, Clark A R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 2002; 22(22)7802–7811, [CSA]
   PubMed Web of Science ®Google Scholar
• Reichardt H M, Tuckermann J P, Gottlicher M, Vujic M, Weih F, Angel P, Herrlich P, Schultz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 2001; 20(24)7168–7173, [CSA]
   PubMed Web of Science ®Google Scholar
• Hart L, Lim S, Adcock I, Barnes P J, Chung K F. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB in asthma. Am J Respir Crit Care Med 2000; 161(1)224–231, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Caramori G, Lim S, Oates T, Chung K F, Barnes P J. Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 2002; 166(3)392–396, [CSA]
   PubMed Web of Science ®Google Scholar
• Cosio B G, Mann B, Ito K, Jazrawi E, Barnes P J, Chung K F, Adcock I M. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 2004; 170: 141–147, [CSA]
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, Livingston E, McMahon A D, Thomson L, Borland W, Thomson N C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003; 168(11)1308–1311, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Ito M, Eliott W M, Cosio B, Caramori G, Kon O M, Barczyk B, Hayashi S, Adcock I M, Hogg J C, Barnes P J. Decreased histone deacetylase activity in chronic obstructive pulmonary disease: relationship to disease severity. N Engl J Med 2005; 352: 1967–1976, [CSA]
   PubMed Web of Science ®Google Scholar
• Hogg J C, Chu F, Utokaparch S, Woods R, Elliott W M, Buzatu L, Cherniak R M, Rogers R M, Sciurba F C, Coxson H O, Pare P D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26)2645–2653, [CSA]
   PubMed Web of Science ®Google Scholar
• Keatings V M, Jatakanon A, Worsdell Y M, Barnes P J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155(2)542–548, [CSA]
   PubMed Web of Science ®Google Scholar
• Culpitt S V, Maziak W, Loukidis S, Nightingale J A, Matthews J L, Barnes P J. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(5 Pt 1)1635–1639, [CSA]
   PubMed Web of Science ®Google Scholar
• Loppow D, Schleiss M B, Kanniess F, Taube C, Jorres R A, Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001; 95(2)115–121, [CSA]
   PubMed Web of Science ®Google Scholar
• Cosio B G, Tsaprouni L, Ito K, Jazrawi E, Adcock I M, Barnes P J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200(5)689–695, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Lim S, Caramori G, Chung K F, Barnes P J, Adcock I M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15(6)1110–1112, [CSA]
   PubMedGoogle Scholar
• Barnes P J, Ito K, Adcock I M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 2004; 363(9410)731–733, [CSA]
   PubMed Web of Science ®Google Scholar
• Montuschi P, Collins J V, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov S A, Barnes P J. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162(3 Pt 1)1175–1177, [CSA]
   PubMed Web of Science ®Google Scholar
• Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S A, Barnes P J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160(1)216–220, [CSA]
   PubMed Web of Science ®Google Scholar
• Baraldi E, Ghiro L, Piovan V, Carraro S, Ciabattoni G, Barnes P J, Montuschi P. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003; 124(1)25–31, [CSA]
   PubMed Web of Science ®Google Scholar
• Caramori G, Papi A. Oxidants and asthma. Thorax 2004; 59(2)170–173, [CSA]
   PubMed Web of Science ®Google Scholar
• Chalmers G W, Macleod K J, Little S A, Thomson L J, McSharry C P, Thomson N C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57(3)226–230, [CSA]
   PubMed Web of Science ®Google Scholar
• Higashimoto Y, Elliott W M, Behzad A R, Sedgwick E G, Takei T, Hogg J C, Hayashi S. Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am J Respir Crit Care Med 2002; 166(2)200–207, [CSA]
   PubMed Web of Science ®Google Scholar
• Retamales I, Elliott W M, Meshi B, Coxson H O, Pare P D, Sciurba F C, Rogers R M, Hayashi S, Hogg J C. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164(3)469–473, [CSA]
   PubMed Web of Science ®Google Scholar
• Hogg J C. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001; 164(10 Pt 2)S71–S75, [CSA]
   PubMed Web of Science ®Google Scholar
• Yamada K, Elliott W M, Brattsand R, Valeur A, Hogg J C, Hayashi S. Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammation. J Allergy Clin Immunol 2002; 109(1)35–42, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito M, Yamada K, Vitalis T Z, Elliott W M, To Y, Hayashi S, Adcock I M, Hogg J C, Barnes P J, Ito K. Latent adenovirus infection decreases histone deacetylase activity in the lungs of ovalbumin-sensitized guinea pigs. Am J Respir Crit Care Med 2004; 169: A78, [CSA]
   Google Scholar
• Macek V, Sorli J, Kopriva S, Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am J Respir Crit Care Med 1994; 150(1)7–10, [CSA]
   PubMed Web of Science ®Google Scholar
• Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, DuBois R M, Kharitonov S A, Barnes P G. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158(5 Pt 1)1524–1527, [CSA]
   PubMed Web of Science ®Google Scholar
• Paredi P, Kharitonov S A, Leak D, Ward S, Cramer D, Barnes P J. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162(2 Pt 1)369–373, [CSA]
   PubMed Web of Science ®Google Scholar
• Antuni J D, Kharitonov S A, Hughes D, Hodson M E, Barnes P J. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax 2000; 55(2)138–142, [CSA]
   PubMed Web of Science ®Google Scholar
• Dezateux C, Walters S, Balfour-Lynn I. Inhaled corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000; 2: CD001915, [CSA]
   PubMedGoogle Scholar
• Richeldi L, Davies H R, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev 2003, 3: CD002880, [CSA]
   Google Scholar
• Rahman I, Gilmour P S, Jimenez L A, Macnee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-κB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 2002; 234–235(1–2)239–248, [CSA]
   PubMed Web of Science ®Google Scholar
• Tomita K, Barnes P J, Adcock I M. The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 2003; 301(2)572–577, [CSA]
   PubMed Web of Science ®Google Scholar
• Marwick J A, Kirkham P A, Stevenson C S, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004; 31(6)633–642, [CSA]
   PubMed Web of Science ®Google Scholar
• Moodie F M, Marwick J A, Anderson C S, Szulakowski P, Biswas S K, Bauter M R, Kilty I, Rahman I. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-κB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J 2004; 18(15)1897–1899, [CSA]
   PubMedGoogle Scholar
• Ito K, Hanazawa T, Tomita K, Barnes P J, Adcock I M. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 2004; 315(1)240–245, [CSA]
   PubMed Web of Science ®Google Scholar
• Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich V. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem 2003; 278(15)12813–12819, [CSA]
   PubMed Web of Science ®Google Scholar
• Buchczyk D P, Grune T, Sies H, Klotz L O. Modifications of glyceraldehyde-3-phosphate dehydrogenase induced by increasing concentrations of peroxynitrite: early recognition by 20S proteasome. Biol Chem 2003; 384(2)237–241, [CSA]
   PubMed Web of Science ®Google Scholar
• Cosio B, Jazrawi E, Ito K, Barnes P J, Adcock I M. Cigarette smoke decreases steroid responsiveness in monocytes: the role of histone deacetylase. Am J Respir Crit Care Med 2003; 167: A804, [CSA]
   Google Scholar
• Biernacki W A, Kharitonov S A, Barnes P J. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003; 58(4)294–298, [CSA]
   PubMed Web of Science ®Google Scholar
• Rahman I, van Schadewijk A A, Crowther A J, Hiemstra P S, Stolk J, Macnee W, De Boer W I. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166(4)490–495, [CSA]
   PubMed Web of Science ®Google Scholar
• Marwick J A, Kirkham P A, Stevenson C S, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004; 31(6)633–642, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Jazrawi E, Cosio B, Barnes P J, Adcock I M. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem 2001; 276(32)30208–30215, [CSA]
   PubMed Web of Science ®Google Scholar
• Garside H J, Stevens A, Farrow S, Normand C, Houle B, Berry A, Maschera B, Ray D. Glucocorticoid ligands specify different interactions with NF-κB by allosteric effects on the glucocorticoid receptor DNA binding domain. J Biol Chem 2004; 279: 50050–50059, [CSA]
   PubMed Web of Science ®Google Scholar
• Schacke H, Schottelius A, Docke W D, Strehlke P, Jaroch S, Schmees N, Rehwinkel I H, Hennekes H, Asdullah K. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci USA 2004; 101(1)227–232, [CSA]
   PubMed Web of Science ®Google Scholar
• Barnes P J. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 2003; 167(6)813–818, [CSA]
   PubMed Web of Science ®Google Scholar
• Ito K, Lim S, Caramori G, Cosio B, Chung K F, Adcock I M, Barnes P J. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002; 99(13)8921–8926, [CSA]
   PubMed Web of Science ®Google Scholar
• Evans D J, Taylor D A, Zetterstrom O, Chung K F, O'Connor B J, Barnes P J. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997; 337(20)1412–1418, [CSA]
   PubMed Web of Science ®Google Scholar
• Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller A, Steinijans V W. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J 1997; 10(12)2754–2760, [CSA]
   PubMed Web of Science ®Google Scholar
• Lim S, Jatakanon A, Gordon D, Macdonald C, Chung K F, Barnes P J. Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 2000; 55(10)837–841, [CSA]
   PubMed Web of Science ®Google Scholar
• Culpitt S V, De Matos C, Russell R E, Donnelly L E, Rogers D F, Barnes P J. Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165(10)1371–1376, [CSA]
   PubMed Web of Science ®Google Scholar
• Barnes P J, Woolcock A J. Difficult asthma. Eur Respir J 1998; 12(5)1209–1218, [CSA]
   PubMed Web of Science ®Google Scholar
• Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression. Biochem Pharmacol 2004; 68(6)1255–1267, [CSA]
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Riley D P, Caputi A P, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001; 53(1)135–159, [CSA]
   PubMed Web of Science ®Google Scholar
• Hansel T T, Kharitonov S A, Donnelly L E, Erin E M, Currie M G, Moore W M, Manning P T, Recker D P, Barnes P J. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 2003; 17(10)1298–1300, [CSA]
   PubMed Web of Science ®Google Scholar
• Ogryzko V V, Schiltz R L, Russanova V, Howard B H, Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996; 87(5)953–959, [CSA]
   PubMed Web of Science ®Google Scholar
• Roth S Y, Denu J M, Allis C D. Histone acetyltransferases. Annu Rev Biochem 2001; 70: 81–120, [CSA]
   PubMed Web of Science ®Google Scholar
• Urnov F D, Wolffe A P. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001; 20(24)2991–3006, [CSA]
   PubMed Web of Science ®Google Scholar
• Gao L, Cueto M A, Asselbergs F, Atadja P. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J Biol Chem 2002; 277(28)25748–25755, [CSA]
   PubMed Web of Science ®Google Scholar
• Waterborg J H. Steady-state levels of histone acetylation in Saccharomyces cerevisiae. J Biol Chem 2000; 275(17)13007–13011, [CSA]
   PubMed Web of Science ®Google Scholar
• Rundlett S E, Carmen A A, Kobayashi R, Bavykin S, Turner B M, Grunstein M. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc Natl Acad Sci USA 1996; 93(25)14503–14508, [CSA]
   PubMed Web of Science ®Google Scholar
• Taunton J, Hassig C A, Schreiber S L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p [see comments]. Science 1996; 272(5260)408–411, [CSA]
   PubMed Web of Science ®Google Scholar
• de Ruijter A J, van Gennip A H, Caron H N, Kemp S, van Kuilenburg A B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370(Pt 3)737–749, [CSA]
   PubMed Web of Science ®Google Scholar
• Yang X J, Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and Clinical Implication. Mol Cell Biol 2005; 25(8)2873–2884, [CSA]
   PubMed Web of Science ®Google Scholar
• Porcu M, Chiarugi A. The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. Trends Pharmacol Sci 2005; 26(2)94–103, [CSA]
   PubMed Web of Science ®Google Scholar
• Peterson C L. HDAC's at work: everyone doing their part. Mol Cell 2002; 9(5)921–922, [CSA]
   PubMed Web of Science ®Google Scholar
• Jones P L, Shi Y B. N-CoR-HDAC corepressor complexes: roles in transcriptional regulation by nuclear hormone receptors. Curr Top Microbiol Immunol 2003; 274: 237–268, [CSA]
   PubMed Web of Science ®Google Scholar
• Fernandes I, Bastien Y, Wai T, Nygard K, Lin R, Cormier O, Lee H S, Eng F, Bertos N R, Pelletier N, Mader S, Han V K, Yang X J. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol Cell 2003; 11(1)139–150, [CSA]
   PubMed Web of Science ®Google Scholar
• Marks P A, Richon V M, Miller T, Kelly W K. Histone deacetylase inhibitors. Adv Cancer Res 2004; 91: 137–168, [CSA]
   PubMed Web of Science ®Google Scholar
• Chen L, Fischle W, Verdin E, Greene W C. Duration of nuclear NF-κB action regulated by reversible acetylation. Science JID-0404511 2001; 293(5535)1653–1657, [CSA]
   Google Scholar
• Ashburner B P, Westerheide S D, Baldwin A SJ. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol JID-8109087 2001; 21(20)7065–7077, [CSA]
   Web of Science ®Google Scholar
• Zhong H, May M J, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-κ B determines its association with CBP/p300 or HDAC-1. Mol Cell 2002; 9(3)625–636, [CSA]
   PubMed Web of Science ®Google Scholar
• Brunet A, Sweeney L B, Sturgill J F, Chua K F, Greer P L, Lin Y, Tran H, Ross S E, Mostoslavsky R, Cohen H Y, Hu L S, Cheng H L, Jedrychowski M P, Gygi S P, Sinclair D A, Alt F W, Greenberg M E. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303(5666)2011–2015, [CSA]
   PubMed Web of Science ®Google Scholar
• Cohen H Y, Miller C, Bitterman K J, Wall N R, Hekking B, Kessler B, Howitz K T, Gorospe M, de Cabo R, Sinclair D A. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305(5682)390–392, [CSA]
   PubMed Web of Science ®Google Scholar
• Yeung F, Hoberg J E, Ramsey C S, Keller M D, Jones D R, Frye R A, Mayo M W. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23(12)2369–2380, [CSA]
   PubMed Web of Science ®Google Scholar
• Sengupta N, Seto E. Regulation of histone deacetylase activities. J Cell Biochem 2004; 93(1)57–67, [CSA]
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ng H H, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999; 13(15)1924–1935, [CSA]
   PubMed Web of Science ®Google Scholar
• Lechner T, Carrozza M J, Yu Y, Grant P A, Eberharter A, Vannier D, Brosch G, Stillman D J, Shore D, Workman J L. Sds3 (suppressor of defective silencing 3) is an integral component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity. J Biol Chem 2000; 275(52)40961–40966, [CSA]
   PubMed Web of Science ®Google Scholar
• You A, Tong J K, Grozinger C M, Schreiber S L. CoREST is an integral component of the Co. Proc Natl Acad Sci USA 2001; 98(4)1454–1458, [CSA]
   PubMed Web of Science ®Google Scholar
• Fischle W, Kiermer V, Dequiedt F, Verdin E. The emerging role of class II histone deacetylases. Biochem Cell Biol 2001; 79(3)337–348, [CSA]
   PubMed Web of Science ®Google Scholar
• Galasinski S C, Resing K A, Goodrich J A, Ahn N G. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem 2002; 277(22)19618–19626, [CSA]
   PubMed Web of Science ®Google Scholar
• Baek S H, Ohgi K A, Rose D W, Koo E H, Glass C K, Rosenfeld M G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and beta-amyloid precursor protein. Cell 2002; 110(1)55–67, [CSA]
   PubMed Web of Science ®Google Scholar
• McKinsey T A, Zhang C L, Olson E N. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol Cell Biol 2001; 21(18)6312–6321, [CSA]
   PubMed Web of Science ®Google Scholar
• McKinsey T A, Zhang C L, Lu J, Olson E N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000; 408(6808)106–111, [CSA]
   PubMed Web of Science ®Google Scholar